Anti-inflammatories and prostate cancer prevention

Yet again we have the presentation of data suggesting that men who take a regular dose of aspirin (or a similar anti-inflammatory agent) may have a lower overall risk for prostate cancer in general and for high-risk prostate cancer in particular … but please note the word “may” and remember that the daily use of aspirin is not free of risk for side effects — some of which can be significant. … READ MORE …

ADT and incidence of bone fractures on in the “real world”

Recent data from the Prostate Cancer Outcomes Study, which followed men diagnosed with prostate cancer for a total of 15 years after their diagnosis, have provided us with valuable information about risk for bone fractures in men with progressive disease. … READ MORE …

What is PI-RADS and why should you care?

PI-RADS is an acronym and it stands for “prostate imaging — reporting and data system” but what it really is is a highly structured method for reporting what can be seen on certain types of prostate-specific magnetic resonance imaging (MRI) scan and how to interpret these data. … READ MORE …

Baldness patterns, genetics, and risk for prostate cancer

According to a newly-published study in the Journal of Clinical Oncology, certain types of male baldness are associated with a heightened risk for aggressive forms of prostate cancer (but this finding really needs to be confirmed in other studies). … READ MORE …

D’Amico on the individualization of prostate cancer risk management

In an interesting article in the September 2014 issue of The ASCO Post, Dr. Anthony D’Amico argues in favor of a future in which individualized approaches to risk will replace PSA screening alone as a means of determining who actually needs to be biopsied and (if necessary) receive treatment for clinically significant prostate cancer. … READ MORE …

Cancer screening re-visited again

An article by Melinda Beck in today’s issue of The Wall Street Journal discusses the complex topic of screening, “over-diagnosis”, and over-treatment of low-risk forms of certain cancers (prostate cancer specifically included). … READ MORE …

Metabolic aberrations and risk for prostate cancer

According to a newly published study of data from > 285,000 European males (the Metabolic Syndrome and Cancer Project), men with metabolic aberrations are at slightly less risk for a diagnosis of prostate cancer compared with men who have normal levels of metabolic factors … but their risk for prostate cancer-specific mortality is similar. … READ MORE …

Follow

Get every new post delivered to your Inbox.

Join 1,152 other followers